Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Tempo Scan Pacific Tbk. (TSPC) vs Mizuho Leasing Indonesia Tbk. (VRNA)

Tempo Scan Pacific Tbk.Trading
Mizuho Leasing Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Tempo Scan Pacific Tbk. dan Mizuho Leasing Indonesia Tbk.: Tempo Scan Pacific Tbk. diperdagangkan di Rp2.580 (kapitalisasi pasar 11,68 T, volume 24 jam 429,7 rb), sedangkan Mizuho Leasing Indonesia Tbk. diperdagangkan di Rp76 (kapitalisasi pasar 432,24 M, volume 24 jam 286,8 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 27× kapitalisasi pasar Mizuho Leasing Indonesia Tbk., dan Tempo Scan Pacific Tbk. lebih aktif diperdagangkan (429,7 rb vs 286,8 rb). Mana yang lebih baik tergantung tujuan investasimu.

TSPCVRNA
Kapitalisasi Pasar
11,68 T432,24 M
Volume
429,7 rb286,8 rb
Lot
4,3 rb2,87 rb
Perputaran
1,11 M22,19 jt
Harga Rata-rata
2.591,6577,35
Nilai Transaksi
1,11 M22,19 jt
Harga Ekuilibrium Indikatif
2.58076
Volume Ekuilibrium Indikatif
1005 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

TSPC
Lihat detail
VRNA
Lihat detail

Tentang Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Selengkapnya di halaman TSPC

Tentang Mizuho Leasing Indonesia Tbk.

PT Verena Oto Finance (the Company) was established under its original name of PT Maxima Perdana Finance base on notarial deed No.43 of Mrs Sri Nanning, S.H, dated on Jul 21, 1993. The Companys articles of association has been amended several times, most recently by notarial deed No. 32 of Fathiah Helmi, S.H., dated Mar 26, 2007, concerning among others, the change in the Companys name, increase authorized, change in par value, and increase paid-up capital.

Selengkapnya di halaman VRNA